Modulated Mid-frequency Whole-body Electromyostimulation and Nutritional Therapy in Gastrointestinal Cancer Patients - Trial NCT06414122
Access comprehensive clinical trial information for NCT06414122 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Cologne and is currently Not yet recruiting. The study focuses on Oesophageal Cancer,Gastric Cancer,Duodenal Cancer,Colorectal Cancer. Target enrollment is 88 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
mid-frequency whole-body electromyostimulation (WB-EMS)
Interventional
other
Sponsor & Location
University of Cologne
Timeline & Enrollment
N/A
Jul 01, 2024
Sep 01, 2026
Primary Outcome
Muscle mass of the quadriceps muscle
Summary
The purpose of this study is to assess the efficacy of modulated mid-frequency whole-body
 electromyostimulation (WB-EMS) combined with nutritional therapy in patients with
 gastrointestinal cancer.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06414122
Non-Device Trial